Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial

Poseida Therapeutics Inc PSTX released early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted allogeneic, T stem cell…

Related Keywords

,Roche Holdings ,Poseida Therapeutics Inc ,News ,Ggregator ,Reaking News ,Uration ,Media ,